Rusty Montgomery (@rmontonio) 's Twitter Profile
Rusty Montgomery

@rmontonio

OKC - UTSW - Boulder. I like genetics, gear, the Sooners, Arsenal, PSG, and the Oxford comma.

ID: 75561738

calendar_today19-09-2009 14:37:19

14,14K Tweet

581 Followers

2,2K Following

Rusty Montgomery (@rmontonio) 's Twitter Profile Photo

Beautiful morning catching the leaves changing before tonight’s storm. Chris Bianchi - still expecting snow above 9000 in Vail/Edwards area??

Beautiful morning catching the leaves changing before tonight’s storm. <a href="/BianchiWeather/">Chris Bianchi</a> - still expecting snow above 9000 in Vail/Edwards area??
BioAge (@bioagelabs) 's Twitter Profile Photo

We are thrilled to announce the closing of BioAge's IPO! As of September 26, we are trading on Nasdaq as $BIOA. This milestone will enable our development of novel therapies that treat metabolic diseases by harnessing the biology of aging. (1/3)

We are thrilled to announce the closing of BioAge's IPO! As of September 26, we are trading on Nasdaq as $BIOA. This milestone will enable our development of novel therapies that treat metabolic diseases by harnessing the biology of aging. (1/3)
Rusty Montgomery (@rmontonio) 's Twitter Profile Photo

Similarly, ending DST would put the latest sunset in Boulder in the 7:30pm range (~June 21). But most of June would see a sunrise in the 4:30am range. Even as a morning person, this seems very early for sun.

BioAge (@bioagelabs) 's Twitter Profile Photo

We're excited to share new scientific research on BioAge’s novel small-molecule NLRP3 inhibitors. NLRP3, a key driver of inflammation, increases activation with age and fuels conditions like obesity and other inflammatory diseases. The study shows that the compound, BAL-0028, is

Rusty Montgomery (@rmontonio) 's Twitter Profile Photo

Very excited to share the advancement of BGE-102, our CNS-penetrant NLRP3 inhibitor, which has completed IND-enabling studies. Below, we share the pharmacology and preclinical efficacy in obesity models and are excited to advance this toward the clinic this year.

Rusty Montgomery (@rmontonio) 's Twitter Profile Photo

We are also very excited to share our expanded efforts in APJ agonism with oral small-molecule and injectable candidates designed to address key unmet needs in obesity.